期刊
TISSUE ENGINEERING PART A
卷 27, 期 5-6, 页码 390-401出版社
MARY ANN LIEBERT, INC
DOI: 10.1089/ten.tea.2020.0110
关键词
in vitro cancer models; patient-derived cells; glioblastoma; stiffness; hydrogels
资金
- NIH [R01DE024772, 1R01AR074502]
- Stanford Child Health Research Institute Faculty Scholar Award
- Stanford Bio-X IIP grant award
- Alliance for Cancer Gene Therapy Young Investigator award grant
This study utilized a biomimetic hydrogel platform with brain-like biochemical cues and tunable stiffness to demonstrate the impact of varying stiffness on patient-derived glioblastoma xenograft (PDTX GBM) cell behavior in 3D. The results showed that hydrogel stiffness influenced PDTX GBM cell proliferation, spreading, and drug resistance, highlighting the potential of 3D hydrogel platforms for mechanistic studies and drug discovery using patient-derived cancer cells.
Cancer progression is known to be accompanied by changes in tissue stiffness. Previous studies have primarily employed immortalized cell lines and 2D hydrogel substrates, which do not recapitulate the 3D tumor niche. How matrix stiffness affects patient-derived cancer cell fate in 3D remains unclear. In this study, we report a matrix metalloproteinase-degradable poly(ethylene-glycol)-based hydrogel platform with brain-mimicking biochemical cues and tunable stiffness (40-26,600 Pa) for 3D culture of patient-derived glioblastoma xenograft (PDTX GBM) cells. Our results demonstrate that decreasing hydrogel stiffness enhanced PDTX GBM cell proliferation, and hydrogels with stiffness 240 Pa and below supported robust PDTX GBM cell spreading in 3D. PDTX GBM cells encapsulated in hydrogels demonstrated higher drug resistance than 2D control, and increasing hydrogel stiffness further enhanced drug resistance. Such 3D hydrogel platforms may provide a valuable tool for mechanistic studies of the role of niche cues in modulating cancer progression for different cancer types. Impact statement Cancer progression has been demonstrated to be accompanied by changes in tissue stiffness; however, how matrix stiffness affects patient-derived glioblastoma xenograft glioblastoma (PDTX GBM) cells in 3D remains elusive. By employing a biomimetic hydrogel platform with brain-mimicking biochemical cues and tunable stiffness (40-26,600 Pa), we demonstrated the effect of varying hydrogel stiffness on PDTX GBM cell proliferation, spreading, and drug resistance in 3D, which cannot be recapitulated using 2D culture. Such 3D hydrogel platforms may provide a valuable tool for mechanistic studies or drug discovery and screening using patient-derived GBM cells.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据